Knoll Capital Management, LLC
MIAMI, FL · CIK 1325083 · 13F filing filed 2023-11-14
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Others nearbyMiami, FL
$96.3m
reported value
+18.0% vs Q2 2023
37positions
70.5%in top 10
12 new
8 added
1 reduced
1 sold out
vs Q2 2023
Holdings, Q3 2023
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| ALDEYRA THERAPEUTICS INC ALDX | $20.3m21.02% | Added +16.2k |
| APPLIED THERAPEUTICS INC APLT | $12.9m13.34% | Added +1.7m |
| BIOHAVEN PHARMACTL HLDG CO L BHVN | $12.8m13.24% | Added +40.0k |
| AVADEL PHARMACEUTICALS PLC SPONSORED ADR | $6.2m6.41% | Added +100.0k |
| HOOKIPA PHARMA INC COM | $3.4m3.53% | Unchanged |
| VERONA PHARMA PLC VRNA | $3.3m3.38% | Unchanged |
| SEABRIDGE GOLD INC COM | $2.6m2.70% | Added +166.6k |
| VANECK ETF TRUST GDX | $2.5m2.57% | Unchanged |
| GLOBAL X FDS SIL | $2.1m2.23% | Unchanged |
| KINROSS GOLD CORP KGC | $2.0m2.08% | New |
| FRANCO NEV CORP FNV | $1.9m2.01% | Added +7.5k |
| WHEATON PRECIOUS METALS CORP WPM | $1.9m2.00% | New |
| AGNICO EAGLE MINES LTD AEM | $1.8m1.89% | New |
| SILVERCREST METALS INC SIL | $1.8m1.88% | Added +240.0k |
| ENTERA BIO LTD ENTX | $1.8m1.87% | Unchanged |
| EQUINOX GOLD CORP EQX | $1.8m1.85% | New |
| VANECK ETF TRUST GDXJ | $1.7m1.78% | Unchanged |
| MAG SILVER CORP MAG | $1.7m1.72% | New |
| BOOZ ALLEN HAMILTON HLDG COR BAH | $1.4m1.47% | Unchanged |
| FIRST MAJESTIC SILVER CORP AG | $1.4m1.46% | New |
| VISA INC V | $1.1m1.16% | Unchanged |
| THERMO FISHER SCIENTIFIC INC TMO | $1.1m1.10% | Unchanged |
| CVS HEALTH CORP CVS | $1.0m1.05% | Unchanged |
| ALTRIA GROUP INC MO | $954.5k0.99% | Unchanged |
| NORTHROP GRUMMAN CORP NOC | $953.0k0.99% | Unchanged |
| ALAMOS GOLD INC NEW AGI | $903.2k0.94% | New |
| LOCKHEED MARTIN CORP LMT | $879.3k0.91% | New |
| ROYAL GOLD INC RGLD | $802.8k0.83% | New |
| PAN AMERN SILVER CORP PAAS | $783.1k0.81% | New |
| OSISKO GOLD ROYALTIES LTD COM | $732.0k0.76% | Unchanged |
| AMYLYX PHARMACEUTICALS INC AMLX | $453.6k0.47% | New |
| Orgenesis, Inc. COM | $393.5k0.41% | Unchanged |
| OMEGA THERAPEUTICS INC COMMON STOCK | $372.0k0.39% | Unchanged |
| OPUS GENETICS INC IRD | $335.0k0.35% | Unchanged |
| NEW PAC METALS CORP NEWP | $233.0k0.24% | New |
| BIOXCEL THERAPEUTICS INC COM | $151.8k0.16% | Added +30.0k |
| OCULAR THERAPEUTIX INC OCUL | $1.3k0.00% | Reduced -199.6k |
Sold out since Q2 2023
| Security | Value then |
|---|---|
| ALTIMMUNE INC ALT | $613.7k173.9k shares |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| ELICIO THERAPEUTICS INC ELTX · 13G · filed 2026-07-08 | 5.3%≈ $4.7m |